These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7601320)

  • 1. The value of information generated by long-term toxicity studies in the dog for the nonclinical safety assessment of pharmaceutical compounds.
    Parkinson C; Lumley CE; Walker SR
    Fundam Appl Toxicol; 1995 Apr; 25(1):115-23. PubMed ID: 7601320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of chronic animal toxicology studies of pharmaceutical compounds: A retrospective analysis.
    Lumley CE; Walker SR
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1007-24. PubMed ID: 4092866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Necessity of 1-year Toxicity Study in Dogs - development of the New Tiered Approach for Toxicity Studies of Pesticide Considering Species Difference in "toxicity profile" and "toxicity dose-response".
    Ono A; Yoshizawa T; Matsumoto K
    Food Saf (Tokyo); 2018 Sep; 6(3):109-117. PubMed ID: 32038897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDER Experience With Juvenile Animal Studies for CNS Drugs.
    Fisher JE; Ravindran A; Elayan I
    Int J Toxicol; 2019; 38(2):88-95. PubMed ID: 30739550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA requirements for nonclinical testing of contraceptive steroids.
    Jordan A
    Contraception; 1992 Dec; 46(6):499-509. PubMed ID: 1493710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the dog in toxicity tests on pharmaceutical compounds.
    Parkinson C; Grasso P
    Hum Exp Toxicol; 1993 Mar; 12(2):99-109. PubMed ID: 8096722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dog as a Second Species for Toxicology Testing Provides Value to Drug Development.
    Bower N; Achanzar WE; Boulifard V; Brinck PR; Kittel B; Vahle JL
    Int J Toxicol; 2022 Dec; 41(6):431-441. PubMed ID: 36112859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The questionable value of long-term animal toxicity studies: a regulatory dilemma.
    Lumley CE; Walker SR
    Arch Toxicol Suppl; 1986; 9():237-9. PubMed ID: 3468901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concept of multispecies testing in industrial toxicology.
    Zbinden G
    Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
    Skov MJ; Beck JC; de Kater AW; Shopp GM
    Int J Toxicol; 2007; 26(5):411-21. PubMed ID: 17963128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of toxicity studies in dogs and impact on the chronic reference dose for conventional pesticide chemicals.
    Dellarco VL; Rowland J; May B
    Crit Rev Toxicol; 2010 Jan; 40(1):16-23. PubMed ID: 20144133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for reducing and refining the use of dogs in the regulatory toxicity testing of pharmaceuticals.
    Broadhead CL; Betton G; Combes R; Damment S; Everett D; Garner C; Godsafe Z; Healing G; Heywood R; Jennings M; Lumley C; Oliver G; Smith D; Straughan D; Topham J; Wallis R; Wilson S; Buckley P
    Hum Exp Toxicol; 2000 Aug; 19(8):440-7. PubMed ID: 11125714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of dogs as second species in regulatory testing of pesticides. Part II: Subacute, subchronic and chronic studies in the dog.
    Spielmann H; Gerbracht U
    Arch Toxicol; 2001 Mar; 75(1):1-21. PubMed ID: 11368059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive steroid toxicology in the Beagle dog and its relevance to human carcinogenicity.
    Owen LN; Briggs MH
    Curr Med Res Opin; 1976; 4(5):309-29. PubMed ID: 64332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL; Andrews PA; Smith DD; DeGeorge JJ; Justice RL; Beitz JG
    Clin Cancer Res; 1999 May; 5(5):1161-7. PubMed ID: 10353752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The timing of preclinical toxicological studies: pharmaceutical company approaches to toxicity testing in support of initial clinical investigations.
    Parkinson C; Thomas KE; Lumley CE
    Regul Toxicol Pharmacol; 1996 Apr; 23(2):162-72. PubMed ID: 8661335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative retrospective analysis of data from short- and long-term animal toxicity studies on 40 pharmaceutical compounds.
    Walker SR; Schuetz E; Schuppan D; Gelzer J
    Arch Toxicol Suppl; 1984; 7():485-7. PubMed ID: 6596020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and toxicological assessment of Neutral Methacrylate Copolymer for GRAS evaluation.
    Eisele J; Haynes G; Kreuzer K; Rosamilia T
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):392-408. PubMed ID: 24012708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.